U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

B3GALT5 beta-1,3-galactosyltransferase 5 [ Homo sapiens (human) ]

Gene ID: 10317, updated on 14-Nov-2024

Summary

Go to the top of the page Help
Official Symbol
B3GALT5provided by HGNC
Official Full Name
beta-1,3-galactosyltransferase 5provided by HGNC
Primary source
HGNC:HGNC:920
See related
Ensembl:ENSG00000183778 MIM:604066; AllianceGenome:HGNC:920
Gene type
protein coding
RefSeq status
REVIEWED
Organism
Homo sapiens
Lineage
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as
B3T5; GLCT5; B3GalTx; B3GalT-V; beta3Gal-T5; beta-3-Gx-T5; beta-1,3-GalTase 5
Summary
This gene encodes a member of a family of membrane-bound glycoproteins. The encoded protein may synthesize type 1 Lewis antigens, which are elevated in gastrointestinal and pancreatic cancers. Alternatively spliced transcript variants using multiple alternate promoters have been observed for this gene. [provided by RefSeq, Sep 2017]
Expression
Biased expression in small intestine (RPKM 5.1), colon (RPKM 4.2) and 3 other tissues See more
Orthologs
mouse all
NEW
Try the new Gene table
Try the new Transcript table

Genomic context

Go to the top of the page Help
See B3GALT5 in Genome Data Viewer
Location:
21q22.2
Exon count:
7
Annotation release Status Assembly Chr Location
RS_2024_08 current GRCh38.p14 (GCF_000001405.40) 21 NC_000021.9 (39612940..39673137)
RS_2024_08 current T2T-CHM13v2.0 (GCF_009914755.1) 21 NC_060945.1 (37997410..38057589)
RS_2024_09 previous assembly GRCh37.p13 (GCF_000001405.25) 21 NC_000021.8 (40984867..41045064)

Chromosome 21 - NC_000021.9Genomic Context describing neighboring genes Neighboring gene H3K4me1 hESC enhancer GRCh37_chr21:40899605-40900600 Neighboring gene H3K27ac hESC enhancer GRCh37_chr21:40907492-40908386 Neighboring gene OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr21:40909281-40910174 Neighboring gene JCAD pseudogene 1 Neighboring gene NANOG hESC enhancer GRCh37_chr21:40923594-40924095 Neighboring gene NANOG hESC enhancer GRCh37_chr21:40931347-40931936 Neighboring gene B3GALT5 antisense RNA 1 Neighboring gene CDK7 strongly-dependent group 2 enhancer GRCh37_chr21:41005119-41006318 Neighboring gene H3K27ac hESC enhancer GRCh37_chr21:41012219-41012718 Neighboring gene H3K27ac hESC enhancer GRCh37_chr21:41011717-41012218 Neighboring gene H3K4me1 hESC enhancer GRCh37_chr21:41015167-41015667 Neighboring gene H3K27ac-H3K4me1 hESC enhancer GRCh37_chr21:41020756-41021302 Neighboring gene B3GALT5 ERV-L LTR promoter Neighboring gene H3K27ac-H3K4me1 hESC enhancer GRCh37_chr21:41044997-41045632 Neighboring gene OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr21:41079003-41079814 Neighboring gene uncharacterized LOC107985499 Neighboring gene immunoglobulin superfamily member 5 Neighboring gene CDK7 strongly-dependent group 2 enhancer GRCh37_chr21:41150548-41151747 Neighboring gene uncharacterized LOC107985500

Genomic regions, transcripts, and products

Go to the top of the page Help

Go to nucleotide: Graphics FASTA GenBank

Expression

Go to the top of the page Help
  • Project title: HPA RNA-seq normal tissues HPA RNA-seq normal tissues
  • Description: RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes
  • BioProject: PRJEB4337
  • Publication: PMID 24309898
  • Analysis date: Wed Apr 4 07:08:55 2018

Bibliography

Go to the top of the pageHelp

GeneRIFs: Gene References Into Functions

What's a GeneRIF?
  1. Highly expressed B3GALT5-AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating beta-catenin/ZEB1 axis.
    Title: Highly expressed B3GALT5-AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating β-catenin/ZEB1 axis.
  2. High expression of B3GALT5 suppresses the galectin-4-mediated peritoneal dissemination of poorly differentiated gastric cancer cells.
    Title: High expression of B3GALT5 suppresses the galectin-4-mediated peritoneal dissemination of poorly differentiated gastric cancer cells.
  3. B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
    Title: B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
  4. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
    Title: High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
  5. Serum level of long noncoding RNA B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer.
    Title: Serum level of long noncoding RNA B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer.
  6. SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells.
    Title: SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells.
  7. B3GALT5 knockout alters gycosphingolipid profile and facilitates transition to human naive pluripotency.
    Title: B3GALT5 knockout alters gycosphingolipid profile and facilitates transition to human naïve pluripotency.
  8. In patients with hepatocellular carcinoma, Kaplan Meier survival analysis showed significantly shorter relapse-free survival for those with high expression of B3GALT5 and shorter overall survival.
    Title: High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.
  9. Here we show that the expression of beta3GalT5 significantly correlates with tumor progression and poor survival in patients, and the globo-series GSLs in breast cancer cells form a complex in membrane lipid raft with caveolin-1 (CAV1) and focal adhesion kinase (FAK) which then interact with AKT and receptor-interacting protein kinase (RIP), respectively
    Title: Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer.
  10. CA19.9 appears as a physiological product whose synthesis strongly depends on the tissue specific and epigenetically-regulated expression of B3GALT5 and ST3GAL3.
    Title: Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation.
Submit: New GeneRIF Correction See all GeneRIFs (17)

Phenotypes

Go to the top of the page Help

Find tests for this gene in the NIH Genetic Testing Registry (GTR)

Review eQTL and phenotype association data in this region using PheGenI

EBI GWAS Catalog

Description
Genome-wide association study of suicide attempts in mood disorder patients.
EBI GWAS Catalog

Variation

Go to the top of the page Help

See Variation Viewer (GRCh37.p13)

HIV-1 interactions

Go to the top of the page Help

Protein interactions

Protein Gene Interaction Pubs
Envelope surface glycoprotein gp160, precursor env Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus PubMed

Go to the HIV-1, Human Interaction Database

Pathways from PubChem

Go to the top of the page

Interactions

Go to the top of the page Help
Products Interactant Other Gene Complex Source Pubs Description

General gene information

Go to the top of the page Help

Markers

Homology

Gene Ontology Provided by GOA

Function Evidence Code Pubs
enables N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity IBA
Inferred from Biological aspect of Ancestor
more info
  
enables N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity TAS
Traceable Author Statement
more info
  
enables protein binding IPI
Inferred from Physical Interaction
more info
 PubMed 
Process Evidence Code Pubs
involved_in lipid metabolic process IEA
Inferred from Electronic Annotation
more info
  
involved_in oligosaccharide biosynthetic process TAS
Traceable Author Statement
more info
  
involved_in protein O-linked glycosylation IBA
Inferred from Biological aspect of Ancestor
more info
  
involved_in protein glycosylation TAS
Traceable Author Statement
more info
 PubMed 
involved_in response to bacterium IEA
Inferred from Electronic Annotation
more info
  
Component Evidence Code Pubs
located_in Golgi apparatus HDA PubMed 
is_active_in Golgi membrane IBA
Inferred from Biological aspect of Ancestor
more info
  
located_in Golgi membrane TAS
Traceable Author Statement
more info
  
located_in endoplasmic reticulum HDA PubMed 

General protein information

Go to the top of the page Help
Preferred Names
beta-1,3-galactosyltransferase 5
Names
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5
homolog of C. elegans Bt toxin resistance gene bre-5
NP_001265579.1
NP_001343265.1
NP_001343267.1
NP_001343268.1
NP_006048.1
NP_149360.1
NP_149361.1
NP_149362.2

NCBI Reference Sequences (RefSeq)

Go to the top of the page Help

NEW Try the new Transcript table

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

mRNA and Protein(s)

  1. NM_001278650.2 → NP_001265579.1  beta-1,3-galactosyltransferase 5 isoform a

    See identical proteins and their annotated locations for NP_001265579.1

    Status: REVIEWED

    Description
    Transcript Variant: This variant (6) represents use of the alternate A promoter and contains an alternate 5' UTR compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AK292951, AW136254, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Related
    ENSP00000480285.1, ENST00000615480.5
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  2. NM_001356336.2 → NP_001343265.1  beta-1,3-galactosyltransferase 5 isoform a

    Status: REVIEWED

    Description
    Transcript Variant: This variant (7) represents use of the alternate A promoter and contains an alternate 5' UTR compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AK292951, AW136254, DQ645732, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Related
    ENSP00000506797.1, ENST00000684187.2
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  3. NM_001356338.2 → NP_001343267.1  beta-1,3-galactosyltransferase 5 isoform a

    Status: REVIEWED

    Description
    Transcript Variant: This variant (8) represents use of the alternate C promoter and contains an alternate 5' UTR compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AW136254, DQ645737, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Related
    ENSP00000507453.1, ENST00000682542.1
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  4. NM_001356339.2 → NP_001343268.1  beta-1,3-galactosyltransferase 5 isoform a

    Status: REVIEWED

    Description
    Transcript Variant: This variant (9) represents use of the alternate C promoter and contains an alternate 5' UTR compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AW136254, DQ645738, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Related
    ENSP00000343318.4, ENST00000343118.6
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  5. NM_006057.3 → NP_006048.1  beta-1,3-galactosyltransferase 5 isoform a

    See identical proteins and their annotated locations for NP_006048.1

    Status: REVIEWED

    Description
    Transcript Variant: This variant (1) represents use of a promoter derived from long terminal repeat (LTR) and encodes isoform a.
    Source sequence(s)
    AB020337, AF064860, AW136254, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Related
    ENSP00000369992.1, ENST00000380618.5
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  6. NM_033170.3 → NP_149360.1  beta-1,3-galactosyltransferase 5 isoform a

    See identical proteins and their annotated locations for NP_149360.1

    Status: REVIEWED

    Description
    Transcript Variant: This variant (2) represents use of a promoter derived from long terminal repeat (LTR) and uses an alternate splice site in the 5' UTR, compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AW136254, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  7. NM_033171.3 → NP_149361.1  beta-1,3-galactosyltransferase 5 isoform a

    See identical proteins and their annotated locations for NP_149361.1

    Status: REVIEWED

    Description
    Transcript Variant: This variant (3) represents use of a promoter derived from long terminal repeat (LTR) and contains an alternate exon in the 5' UTR, compared to variant 1.
    Source sequence(s)
    AB020337, AF064860, AW136254, KF457302
    Consensus CDS
    CCDS13667.1
    UniProtKB/Swiss-Prot
    A8KA86, D3DSI3, Q2M3L5, Q53Z19, Q9NY96, Q9P1X6, Q9P1X7, Q9Y2C3
    Conserved Domains (1) summary
    cl21608
    Location:71 → 261
    Galactosyl_T; Galactosyltransferase

  8. NM_033172.3 → NP_149362.2  beta-1,3-galactosyltransferase 5 isoform b

    Status: REVIEWED

    Description
    Transcript Variant: This variant (4)represents use of a promoter derived from long terminal repeat (LTR), but differs in the 5' UTR and initiates translation at an alternate start codon, compared to variant 1. The encoded isoform (b) has a longer N-terminus, compared to isoform a.
    Source sequence(s)
    AB020337, AF064860, AW136254, KF457302
    UniProtKB/TrEMBL
    A0A0A0MS93
    Conserved Domains (1) summary
    cl21608
    Location:75 → 265
    Galactosyl_T; Galactosyltransferase

RefSeqs of Annotated Genomes: GCF_000001405.40-RS_2024_08

The following sections contain reference sequences that belong to a specific genome build. Explain

Reference GRCh38.p14 Primary Assembly

Genomic

  1. NC_000021.9 Reference GRCh38.p14 Primary Assembly

    Range
    39612940..39673137
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Alternate T2T-CHM13v2.0

Genomic

  1. NC_060945.1 Alternate T2T-CHM13v2.0

    Range
    37997410..38057589
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Suppressed Reference Sequence(s)

The following Reference Sequences have been suppressed. Explain

  1. NM_033173.1: Suppressed sequence

    Description
    NM_033173.1: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript.
Nucleotide Protein
Heading Accession and Version
Protein Accession Links
GenPept Link UniProtKB Link
Q9Y2C3.1 GenPept UniProtKB/Swiss-Prot:Q9Y2C3

Gene LinkOut

The following LinkOut resources are supplied by external providers. These providers are responsible for maintaining the links.

Chemical Information
Molecular Biology Databases
Research Materials
Tools
Miscellaneous